APOE and dementia: When stratifying by APOE-ε4 carrier status, the risk of incident dementia associated with multimorbidity was greater in noncarriers (HR, 1.96 [95% CI, 1.81-2.11]) and attenuated in carriers (HR, 1.39 [95% CI, 1.30-1.49]).